Abbott earned FDA approval for its dissolving stent designed to unclog arteries below the knee. This marks the first time the FDA has approved a stent or drug-coated balloon to help arteries stay open below the knee.
CardioCell's in Phase 2a trials with its stem cell therapy for chronic heart failure. Its approach is to infuse stem cells into a patient's system taht stimulate the heart cells into to working again.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
Intact Vascular, the maker of a device meant to repair tears in the arteries that are typical after an angioplasty, just raised $3 million, according to an SEC filing. The Pennsylvania company’s product is geared toward the peripheral artery disease set: When arteries narrow or get blocked, patients often require balloon angioplasties to open up the circulatory […]
Peripheral artery disease (PAD) affects about 8 million people in the US alone, according to the American Heart Association, and it can lead to strokes or heart attacks. Diagnosis is often inaccurate and time consuming, and many people who have the problem are asymptomatic. A Doppler Ultrasound and the Ankle Brachial Index (ABI) scale are […]